About Us
Pharmaxi MRM Inc. was created to provide sponsors with a US-based contracting CRO supported by a global execution model. We combine the clinical operations experience and delivery capabilities of Pharmaxi Ltd (Europe) with the strategic and regional reach of MRM BioEnt (UAE)
What this means for sponsors:
  • -1-
    Clear governance and accountability
  • -2-
    Senior oversight and operational execution depth
  • -3-
    Regional access and partner ecosystems
  • -4-
    Our managers are always ready to answer your questions. You can call us during the weekends and at night.
Pharmaxi MRM Inc.was established as a strategic joint venture between Pharmaxi Ltd. and MRM BioEnt to expand high-quality clinical research services into the U.S. and global biotech markets. Pharmaxi brings more than a decade of experience as an established clinical research organization with operational infrastructure and investigator networks, while MRM BioEnt contributes strategic development expertise, international partnerships, and investment capabilities within the biotechnology sector.

This joint-venture model combines proven clinical execution with forward-looking innovation, allowing Pharmaxi MRM Inc.to support emerging biotech sponsors with flexible, cost-efficient CRO services. By integrating operational strength with strategic guidance, Pharmaxi MRM Inc.helps accelerate the development of novel therapies from early clinical stages to regulatory approval.
Our Story
Pharmaxi MRM Inc.is led by a multidisciplinary team of clinical research, regulatory, and biotechnology professionals with extensive experience in global drug development and clinical trial management. Our leadership combines the operational expertise of Pharmaxi’s established CRO infrastructure with the strategic vision and investment background of MRM BioEnt, creating a strong foundation for supporting innovative biotech sponsors.

The organization brings together clinical project managers, medical experts, regulatory specialists, biostatisticians, data managers, and quality professionals who work collaboratively to deliver high-quality clinical research services. With international experience across multiple therapeutic areas and regulatory environments, the Pharmaxi MRM Inc.team ensures efficient study execution, scientific rigor, and strict adherence to global regulatory standards.
Leadership & Team
Pascal Brabant
Pascal Brabant brings more than 35 years of experience in clinical research and clinical operations. With medical training and prior service in the Canadian Armed Forces, he began his clinical career at the Montreal Heart Institute, where he spent 10 years involved in cardiovascular medicine and clinical research. He later held senior management roles in global CROs including Covance and Keyrus Life Science, and served as a therapeutic lead at Wyeth Pharmaceuticals Canada, overseeing programs in cardiovascular, internal medicine, and infectious diseases. He subsequently held the position of Director of Clinical Operations at Methylene. Over the past 15 years, Mr. Brabant has worked as a clinical operations consultant, supporting sponsors and research organisations across North America and globally. He currently collaborates with Pharmaxi MRM, providing strategic guidance in global clinical operations with a particular focus on North American activities.
Hélène Dubreuil
Hélène Dubreuil is a registered nurse with more than 30 years of experience in healthcare and clinical research. She began her career with 10 years of clinical nursing experience within the Quebec Health Network before transitioning to clinical research. She spent six years as a clinical research associate with major organisations including Quintiles and Pfizer, gaining extensive experience in site monitoring and clinical trial oversight. Over the past 20 years, Ms. Dubreuil has worked as an independent consultant specialising in site monitoring, monitoring team leadership, and quality assurance site auditing. She currently supports Pharmaxi MRM by providing expertise in site monitoring, management of monitoring teams, and site auditing to ensure high standards of clinical trial conduct and regulatory compliance.
Pharmaxi MRM Inc.operates through a strategically positioned international footprint spanning the United States, Europe, and the Middle East & North Africa (MENA) region. The company’s U.S. presence supports engagement with global biotech sponsors and regulatory alignment with the U.S. FDA, while Pharmaxi’s established operational infrastructure in Ukraine provides access to experienced clinical research teams, leading investigators, and well-developed clinical trial sites across Eastern Europe.

Through its connection with MRM BioEnt in UAE, Pharmaxi MRM Inc.extends its reach into the rapidly growing MENA biotechnology and healthcare markets. This cross-regional structure enables efficient trial execution, competitive cost structures, and access to diverse patient populations for global clinical development programs.
Global Footprint (USA + Europe + MENA)
Made on
Tilda